---
FDA Novartis Late with Dog Painkiller Reports
FDA Novartis Late with Dog Painkiller Reports -- Posted by Roman Bystrianyk on 12-28-04 09:52
http://www.healthsentinel.com/news.php?event=news_print_list_item&id=502
"FDA Novartis Late with Dog Painkiller Reports", Reuters, December 28,
2004,
Link:
http://www.reuters.com/newsArticle.jhtml?type=domesticNews&storyID=7193085
Novartis AG failed to give the government prompt, accurate reports
about deaths of dogs treated with a painkiller in the same class of
medicines now linked to heart problems in humans, U.S. regulators have
charged in a letter.
The drug, Deramaxx, is a COX-2 inhibitor approved for relieving
arthritis and post-surgical pain in dogs.
Similar drugs for people are under heavy scrutiny after studies
associated them with heart attacks and strokes. One of the drugs, Merck
& Co Inc.'s Vioxx, was pulled from the market because of safety risks.
Death has been reported "in rare situations" when dogs were treated
with Deramaxx, according to the drug's label instructions.
The Food and Drug Administration, in a warning letter dated Nov. 29,
said Novartis Animal Health Services should have forwarded complaints
about deaths and health problems in dogs given Deramaxx within 15
working days, but in some cases delayed as long as 10 months. Some
reports, including ones involving deaths, appeared to have incorrect
dates, the FDA said.
"Novartis failed to submit timely and accurate information to the FDA
regarding serious (adverse drug experiences) associated with the
administration of its FDA-approved animal drug product Deramaxx ...
during its first year of marketing," the FDA said.
The company also failed to submit proper information about
post-approval studies of Deramaxx, the FDA charged. The drug is known
generically as deracoxib.
Novartis officials could not immediately be reached for comment.
The FDA sends dozens of warning letters per year. Most of the issues
raised are resolved without further regulatory action, although the
letters sometimes lead to tougher steps such as product seizures.
The warning letter to Novartis is posted on the FDA Web site at
http:/www.fda.gov/foi/warning_letters/g5108d.pdf
Related
Discussion:
Cellular phones and elevated iron levels (10 posts)
by doe - Last post on: 06-18-04 07:13
If, however, FeCl(2) with final concentration 10 microg/ml was added to the
lymphocyte suspensions to stimulate ROS production, after both durations of
exposure, the magnitude of fluorescence (ROS level during the experiment) was
significantly greater in the exposed lymphocytes.
Bioelec... (Read More)
Xanthones (1 posts)
by Linda Renfroe - Last post on: 07-28-04 20:17
Mangosteen: The Queen of Fruits!
XANTHONES repair cells and have positive effects on
nearly all of the body's systems.
The rind of the Mangosteen contains 41 xanthones and
makes a delicious juice that is making the medical
association do a double take.
Is indorsed by many doctors and only 18 ... (Read More)
6851252 CD-R, DVD R, DVD CASES LOWEST PRICE! 68 (1 posts)
by mark deguire - Last post on: 05-23-05 13:23
media4sale.com offers innovative and quality media, CD/DVD packaging and
other computer accessories at the best prices. We pride ourselves in
service, quality and commitment and are certain that our standards will
exceed expectations.
http://www.media4sale.com
Medi... (Read More)
Freedom in America (1 posts)
by R B - Last post on: 01-15-04 02:58
Americans will never be free until they have affordable health care in
this country. You can work all your life and lose everything you have
with one trip to the hospital.
nohype76@hotmail.com
... (Read More)
Top
Discussions From Our Archives
Is Your Home a Healthy Home?
Hypertension and Smoking Decreasing Among U.S. Adults with Diabetes
Low Adherence to Guidelines for Nephropathy and Hypertension in Diabetics
traveling with food allergies
Tuberculosis Linked to Arthritis Drugs
Other
Discussion Categories
Diabetes Symptoms
Health Care Policy
Health Care Providers HMO
Arthritis Symptoms
| 
